Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics(clinical),General Medicine
Reference10 articles.
1. Tye C, Mcewen FS, Liang H, Underwood L, Woodhouse E, Barker ED, Sheerin F, Yates JR, Bolton PF, Tuberous Sclerosis 2000 Study Group, Higgins N. Long-term cognitive outcomes in tuberous sclerosis complex. Dev Med Child Neurol. 2020;62(3):322–9.
2. de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC). Eur Child Adolesc Psychiatry. 2007;16(1):16–24.
3. De Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D’Amato L, d’Augères GB, Ferreira JC, Feucht M. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. Orphanet J Rare Dis. 2018;13(1):157.
4. De Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D’Amato L, Beaure d’Augères G, Ferreira JC, Feucht M. Tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): new findings on age, sex, and genotype in relation to intellectual phenotype. Front Neurol. 2020;11:603.
5. Roman-Urrestarazu A, van Kessel R, Allison C, Matthews FE, Brayne C, Baron-Cohen S. Association of race/ethnicity and social disadvantage with autism prevalence in 7 million school children in England. JAMA Pediatr. 2021. https://doi.org/10.1001/jamapediatrics.2021.0054.